摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,4aR,6S,7S,8R,8aR)-7,8-dimethoxy-2,6-diphenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine | 511274-41-2

中文名称
——
中文别名
——
英文名称
(2R,4aR,6S,7S,8R,8aR)-7,8-dimethoxy-2,6-diphenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine
英文别名
——
(2R,4aR,6S,7S,8R,8aR)-7,8-dimethoxy-2,6-diphenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine化学式
CAS
511274-41-2
化学式
C21H24O5
mdl
——
分子量
356.419
InChiKey
ZIGZMEZHXMZEPZ-ZWJPJJENSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    46.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
    申请人:Sas Benedikt
    公开号:US20050090452A1
    公开(公告)日:2005-04-28
    Bicyclic carbohydrates for the treatment of infections caused by herpseviridae, and in particular cytomegalovirus. The invention consists of the novel bicyclic carbohydrates the generic structure of which is: wherein R 1 is either -Bn or -Ph; R 2 and R 3 are either -alkyl, -aryl, -allyl, or —H; R 4 and R 5 form a ring and are either —CH(Ph)- or —CH(aryl)- and X is either O, N or S.
    用于治疗由疱疹病毒科感染引起的感染,特别是巨细胞病毒的双环碳水化合物。该发明包括新型双环碳水化合物,其通用结构如下:其中R1为-Bn或-Ph;R2和R3为-烷基,-芳基,-烯丙基或-H;R4和R5形成一个环,可以是-CH(Ph)-或-CH(芳基)-,X可以是O,N或S。
  • Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
    申请人:Kemin Pharma Europe
    公开号:EP2168972A2
    公开(公告)日:2010-03-31
    A compound of the formula : wherein R1 is -H, -SPh, -Ph, -allyl or -benzyl; R2 is -H, -Et, -allyl, -Me or -benzyl; R3 is -H, -Et, -Me, -allyl or -benzyl; and R4 and R5 are both -OH or R4 and R5 together form a ring and are -OCH(Ph)O- ; or a pharmaceutically active derivative thereof. Pharmaceutical compositions comprising the above compounds and their use in therapy are also provided.
    式中的化合物: 其中 R1 是-H、-SPh、-Ph、-烯丙基或-苄基; R2 是-H、-Et、-烯丙基、-Me 或-苄基 R3 是-H、-Et、-Me、-烯丙基或-苄基;以及 R4 和 R5 都是-OH,或者 R4 和 R5 共同形成一个环,并且是-OCH(Ph)O-; 或其药用活性衍生物。 还提供了包含上述化合物的药物组合物及其在治疗中的用途。
  • US7534871B2
    申请人:——
    公开号:US7534871B2
    公开(公告)日:2009-05-19
  • A Convergent Ring-Closing Metathesis Approach to Carbohydrate-Based Macrolides with Potential Antibiotic Activity
    作者:Petra Blom、Bart Ruttens、Steven Van Hoof、Idzi Hubrecht、Johan Van der Eycken、Benedikt Sas、Johan Van hemel、Jan Vandenkerckhove
    DOI:10.1021/jo051021k
    日期:2005.11.1
    An efficient convergent approach has been developed for the construction of novel, non-natural, carbohydrate-based macrolides. The key step in the synthesis is the formation of the macrocyclic ring via a ring-closing metathesis reaction. The obtained macrolide analogues have been screened for biological activity against, Gram-positive and Gram-negative bacteria, including resistant strains, yeasts, and molds.
  • Synthesis and screening of bicyclic carbohydrate-based compounds: A novel type of antivirals
    作者:Steven Van Hoof、Bart Ruttens、Idzi Hubrecht、Gert Smans、Petra Blom、Benedikt Sas、Johan Van hemel、Jan Vandenkerckhove、Johan Van der Eycken
    DOI:10.1016/j.bmcl.2005.12.048
    日期:2006.3
    A small library of bicyclic carbohydrate derivatives was synthesized and screened. A strong and selective activity against cytomegalovirus was found. Structure-activity relationship for this new type of antivirals is discussed. (C) 2005 Elsevier Ltd. All rights reserved.
查看更多